Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines

By Kim S.K.   Ragupathi G.   Musselli C.   Choi S.-J.   Park Y.S.   Livingston P.O.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 597-603

Elsevier

Access to resources Recommend Favorite

Dendritic cell KLH loading requirements for efficient CD4 + T-cell priming and help to peptide-specific cytotoxic T-cell response, in view of potential use in cancer vaccines

By Millard A.L.   Ittelet D.   Schooneman F.   Bernard J.  

Vaccine, Vol. 21, Iss. 9, 2003-02 ,pp. : 869-876

Elsevier

Access to resources Recommend Favorite

Comparison of antibody titers after immunization with monovalent or tetravalent KLH conjugate vaccines

By Ragupathi G.   Cappello S.   Yi S.S.   Canter D.   Spassova M.   Bornmann W.G.   Danishefsky S.J.   Livingston P.O.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1030-1038

Elsevier

Access to resources Recommend Favorite

Immune response to influenza vaccination in institutionalized elderly: effect on different T-cell subsets

By McElhaney J.E.   Gravenstein S.   Upshaw C.M.   Hooton J.W.   Krause P.   Drinka P.  

Vaccine, Vol. 16, Iss. 4, 1998-02 ,pp. : 403-409

Elsevier

Access to resources Recommend Favorite

Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers

By Jung M.-C.   Gruner N.   Zachoval R.   Schraut W.   Gerlach T.   Diepolder H.   Schirren C.-A.   Page M.   Bailey J.   Birtles E.   Whitehead E.   Trojan J.   Zeuzem S.   Pape G.R.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3598-3612

Elsevier

Access to resources Recommend Favorite